Research Topics
| Jerrold HillSummaryAffiliation: Institute for the Study of Aging Country: USA Publications
| Collaborators
|
Detail Information
Publications
Validation of a brief screen for cognitive impairment (BSCI) administered by telephone for use in the medicare populationJerrold Hill
Institute for the Study of Aging, New York, New York 10019, USA
Dis Manag 8:223-34. 2005..The use of brief screening instruments for dementia, such as the one validated here, will be increasingly important for the effective management of dementia and other chronic diseases where dementia is a coexisting condition...- Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling populationJerrold Hill
Institute for the Study of Aging, New York, NY 10019, USA
J Alzheimers Dis 8:43-50. 2005..While vascular dementia (VaD) is the second most prevalent dementia diagnosis, little is known about healthcare use and costs for VaD... - Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control studyShaoli Lu
Institute for the Study of Aging, New York, New York 10019, USA
Am J Geriatr Pharmacother 3:92-102. 2005..However, there are limited studies examining the impact on health care costs of cholinesterase inhibitors prescribed in routine clinical practice... - Economics of dementia and pharmacoeconomics of dementia therapyHoward Fillit
Institute for the Study of Aging, Inc, New York, New York 10019, USA
Am J Geriatr Pharmacother 3:39-49. 2005..In 1997, the cost of managing patients with Alzheimer's disease and other dementias was estimated at US dollar 100 billion. Direct medical costs are compounded by indirect costs of care, including unpaid care and loss of earnings... - The economic benefits of acetylcholinesterase inhibitors for patients with Alzheimer disease and associated dementiasHoward Fillit
Institute for the Study of Aging, Inc, New York, NY 10453, USA
Alzheimer Dis Assoc Disord 18:S24-9. 2004.... - The costs of vascular dementia: a comparison with Alzheimer's diseaseHoward Fillit
Institute for the Study of Aging, New York, NY 10153, USA
J Neurol Sci 203:35-9. 2002..To estimate the costs of Medicare patients with vascular dementia (VaD). To compare the costs of VaD to Alzheimer's disease (AD) and controls without dementia... 
Impact of a geriatric case management program on health plan costsGloria Picariello
HIP Health Plan of New York, New York, New York 10041, USA
Popul Health Manag 11:209-15. 2008..A GCM program was successfully implemented in a large Medicare Advantage program. The reductions in health care costs achieved through GCM exceeded program costs resulted in meaningful savings for the health plan...- Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementiasJerrold Hill
Health Economics Research and Outcomes Evaluation, Jeffersonville, PA 19403, USA
Pharmacoeconomics 24:265-80. 2006..This study estimated the relationship between the degree of functional impairment in patients with ADOD and their healthcare costs and prevalence of institutionalisation... - Utilization of darbepoetin alfa in relation to cancer patients' hemoglobin levelsGregory Hess
Surveillance Data, Inc, Plymouth Meeting, PA 19462, USA
Curr Med Res Opin 24:815-9. 2008..This study analyzed adherence with recommendations in administration of darbepoetin (DA) to cancer patients...